News About: Pharm. Industry
Wholesalers struggling to maintain wholesaler margin
Domestic wholesalers have called for pharmaceutical makers not to lower wholesaler margin to survive in more harsh pharmaceutical condition these days.
The Korea Pharmaceutical Wholesaler Association will release i...
GSK wins administrative suit over resale price
Korea’s top court has recently dismissed claims by the Fair Trade Commission in an administrative lawsuit against GlaxoSmithKline over resale price maintenance.
The Supreme Court upheld lower court’s rulings in fav...
Korean drug manufacturers’ dependence on co-marketing tops 20% in revenue
The domestic firms’ dependence on the co-promotion of other companies’ original brands reached 20 percent in earnings last year, according to Yakup Shinmoon.
The trade paper said that 106 Korean companies achieved ...
KPMA to help pharmaceutical firms go global
The Korea Pharmaceutical Manufacturers Association is ramping up its overseas expansion drive, with the aim to boost drug sales of its member companies.
“We will execute our expansion plan step by step, targeting m...
Takeda’s sales policy sparks protest
Local wholesalers have still gone up in arms against Takeda Korea’s margin policy, saying it will be a threat to their business.
They will establish an emergency committee with an aim to get pharmacies and hospital...
KFDA to crack down on false drug labeling
The Korea Food and Drug Administration will not tolerate any violation of drug makers on country of origin, as the Korea Customs Service has recently discovered the false drug labeling of a foreign-invested pharmaceut...
Takeda’s sales policy ignites controversy
Takeda is pushing up with its sales policy to increase its revenues of Basen tablets and Madipine tablets in Korea, but faces vigorous challenges from domestic wholesalers.
With a thinner wholesaler margin, Takeda ...
JW to conduct Phase I trial for new anticancer medicine
JW Pharmaceutical has recently announced that it will conduct Phase I clinical trial for CWP231A, a candidate anticancer medicine that interrupts biochemical signals to eradicate leukemia stem cells without affecting ...
Abbott Korea names new executives
Abbott Korea has recently promoted two directors Kim Bong-ho and Park Chul-min as managing directors for Medical Diagnostics Business Unit.
Kim, 52, entered the company in 1986 after in 1980 after graduating from H...
Listed pharmaceutical companies’ earnings become thinner
The average earnings of 36 firms listed on the main bourse have been aggravating annually due to tough regulations and intense competition at home, Yakup Shinmoon said recently.
The trade paper said that the averag...
